Gonadotropin-releasing hormone antagonists in controlled ovarian stimulation

被引：0

作者：

Diedrich, Klaus ^{[1
]}

Felberbaum, Ricardo ^{[2
]}

Al-Hasani, Safaa ^{[1
]}

机构：

[1] Univ Klinikum Schleswig Holstein, Klin Frauenheilkunde, Ratzeburger Allee 160, D-23538 Lubeck, Germany

[2] Klin Verbund Allgau, Klin Gynakol & Geburtshilfe Kempten & Immenstadt, Kempten, Germany

来源：

GYNAKOLOGE | 2020年 / 53卷 / 08期

关键词：

Ovarian hyperstimulation syndrome; Ovulation induction; Pregnancy rate; Reproductive techniques; assisted; Progesterone; INVITRO FERTILIZATION; CETRORELIX;

D O I：

10.1007/s00129-020-04634-y

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ovarian stimulation is one of the most important stages in assisted reproduction. The first attempts at stimulation with gonadotropins and gonadotropin-releasing hormone (GnRH) agonists were costly and relatively unsuccessful with many cases of overstimulation. Only the introduction of GnRH antagonists resulted in important progress. The advantages are a shorter duration of treatment and a simplified treatment with less side effects (overstimulation syndrome). In addition, the live birth rate is comparable with that of earlier antagonist protocols. Novel stimulation protocols could be developed with the important possibility to avoid overstimulation (oocyte freezing). In Germany and Europe approximately 70% of the patients are stimulated with the gonadotropins/antagonists protocol.

引用

页码：517 / 521

页数：5

共 50 条

[21] EFFECTS OF GONADOTROPIN-RELEASING HORMONE ANTAGONISTS ON OVARIAN RECRUDESCENCE IN THE LIZARD, ANOLIS-CAROLINENSIS
TOKARZ, RR
[J]. AMERICAN ZOOLOGIST, 1983, 23 (04): : 909 - 909
[22] Gonadotropin-releasing hormone antagonists in the treatment of uterine leiomyoma
Felberbaum, Ricardo E.
Kuepker, Wolfgang
Balogh, Balint
Diedrich, Klaus
[J]. GYNAKOLOGE, 2020, 53 (08): : 529 - 536
[23] Gonadotropin-releasing hormone/gonadotropin-releasing hormone receptor signaling in the placenta
Sasaki, Kirsten
Norwitz, Errol R.
[J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2011, 18 (06) : 401 - 408
[24] The novel oral gonadotropin-releasing hormone receptor antagonist relugolix is a new option for controlled ovarian stimulation cycles
Komiya, Shinnosuke
Tsuzuki-Nakao, Tomoko
Asai, Yoshiko
Inoue, Tomoko
Morimoto, Yoshiharu
Okada, Hidetaka
[J]. REPRODUCTIVE MEDICINE AND BIOLOGY, 2022, 21 (01)
[25] Controlled Ovarian Stimulation Using a Long Gonadotropin-Releasing Hormone Antagonist Protocol: A Proof of Concept and Feasibility Study
Weissman, Ariel
Ravhon, Amir
Steinfeld, Zohar
Nahum, Hana
Golan, Abraham
Levran, David
[J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2013, 76 (02) : 113 - 118
[26] Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists
Rabinson, Jacob
Ashkenazi, Jacob
Homburg, Roy
Meltcer, Simion
Anteby, Eyal Y.
Orvieto, Raoul
[J]. FERTILITY AND STERILITY, 2009, 91 (04) : 1473 - 1475
[27] A novel orally active gonadotropin-releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology
Hamada, Michiko
Horikawa, Michiharu
Ensaka, Chie
Enomoto, Megumi
Ishii, Rena
Toriumi, Rena
Tachibana, Naoyuki
Taketani, Yuji
[J]. REPRODUCTIVE MEDICINE AND BIOLOGY, 2022, 21 (01)
[28] Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
Gruendker, Carsten
Emons, Guenter
[J]. CELLS, 2021, 10 (02) : 1 - 17
[29] Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer
Carsten Gründker
Günter Emons
[J]. Reproductive Biology and Endocrinology, 1 (1)
[30] THE EFFECT OF GONADOTROPIN-RELEASING HORMONE ON OVARIAN ESTRADIOL SECRETION
KLETZKY, OA
DAVAJAN, V
MISHELL, DR
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 142 (04) : 427 - 431

← 1 2 3 4 5 →